Related Experiment Videos
Stability of anticancer activity induced by cellular differentiation
P B Maercklein1, D N Estervig, R E Scott
1Section of Experimental Pathology, Mayo Clinic/Foundation, Rochester, Minnesota.
Abstract:
Human and murine cells can express anticancer activity which we define as any biologic process that can prevent or inhibit the expression of the transformed phenotype. The existence of anticancer activities has been demonstrated by many systems, including the fusion of normal cells with tumorigenic cells and the implantation of cancer cells into specific embryonic sites. Furthermore, cellular differentiation has recently been shown to regulate the expression of anticancer activity without limiting a cell's proliferative potential. Those results show that reversible nonterminal differentiation (NTD) induces 3T3T mesenchymal stem cells to become resistant to transformation by physical or chemical carcinogens or oncogene products and NTD induces spontaneously transformed 3T3T cells to revert to a benign state and to become resistant to retransformation. In addition, NTD induces SV40 T-antigen transformed 3T3T cells to revert to a nontransformed state that prevents growth in soft agarose. Data are now presented that define the relative stability of these differentiation-induced anticancer activities. Anticancer activity induced by NTD in 3T3T cells is shown to have a mean stability of 55 population doublings (PD) and a maximum stability of 88 PD. Anticancer activity induced by NTD in spontaneously transformed 3T3T cells shows a similar stability with a mean of 55 PD and a maximum of 95 PD. Finally, in SV40-3T3T cells, the induction of NTD suppresses soft agarose growth for a maximum of 20-30 PD. These results demonstrate that three forms of differentiation-induced anticancer activity are stable for an extended number of population doublings.
Insights
Reversible nonterminal differentiation (NTD) confers stable anticancer activity in cells, preventing transformation and promoting reversion to a benign state. This induced resistance persists through numerous cell divisions, highlighting differentiation
Area of Science:
- Cell Biology
- Cancer Research
- Stem Cell Biology
Background:
- Cells possess inherent anticancer activities that inhibit the transformed phenotype.
- Cellular differentiation can regulate anticancer activity without affecting proliferative potential.
Purpose of the Study:
- To investigate the stability of anticancer activities induced by reversible nonterminal differentiation (NTD).
- To determine the duration of resistance to transformation and reversion to a benign state following NTD.
Main Methods:
- Induction of NTD in 3T3T mesenchymal stem cells and transformed variants (spontaneously transformed and SV40-3T3T cells).
- Assessment of resistance to chemical carcinogens, oncogene products, and reversion of transformed phenotypes.
- Quantification of the stability of induced anticancer activity in terms of population doublings (PD).
Main Results:
- NTD confers resistance to transformation in 3T3T cells.
- NTD induces reversion to a benign state in spontaneously transformed cells and a non-transformed state in SV40-transformed cells.
- Differentiation-induced anticancer activities demonstrated significant stability, with mean durations of 55 PD and maximums up to 95 PD across different cell types.
Conclusions:
- Reversible nonterminal differentiation induces stable anticancer activities in various cell models.
- These differentiation-induced anticancer effects are sustained over extended periods of cell proliferation.
- NTD represents a promising mechanism for establishing long-lasting cellular resistance to transformation and cancer progression.